Dr. Boaz Arzi, DVM, DAVDC, DEVDC, FF-AVDC-OMFS
Dr. Boaz Arzi is an Associate Professor of Dentistry and Oral Surgery in the Department of Surgical and Radiological Sciences. Dr. Arzi has been an active member of the VIRC since its inception—serving as the Director of Clinical Studies and as a member of the education committee. He is also a Diplomate of the American and the European Veterinary Dental Colleges (DAVDC, DEVDC) and a board member of the North American Veterinary Regenerative Medicine Association (NAVRMA). Dr. Arzi focuses his clinical and research expertise on oral maxillofacial disorders and surgery and regenerative solutions in dogs and cats. He is a co-PI on the long-standing program utilizing adipose-derived mesenchymal stem cells (MSC) to treat feline gingivostomatitus. He also serves as a co-PI on the use of rhBMP-2 for mandibular reconstruction. Dr. Arzi collaborates with the biomedical engineering group at UC Davis for the development of biological solutions to temporomandibular joint (TMJ) disorders in humans. Ultimately, Dr. Arzi’s work is translational with the aim of One Health treatment modalities for both human and animal health
Lisa Even, M.S.
VIRC Associate Director
Lisa Even is the current Associate Director of the VIRC and is responsible for overall program and regenerative medicine clinical trial management. Prior to joining the VIRC, Lisa spent 10 years with the Ferrara lab in the department of Biomedical Engineering as an SRAIV where she served as the manager of in vivo operations of a cancer research and imaging laboratory and holds co-authorship on over 40 publications. Before joining BME, Lisa worked at The Jackson Laboratory West performing large scale pre-clinical studies and prior to that worked for many years as a veterinary technician in both Davis and San Francisco. She is an alumni of UC Davis with a B.S. degree in Animal Science and a M.S. degree in Comparative Pathology and holds the Registered Laboratory Animal Technologist (RLATg) certification with AALAS.
Dr. Dori Borjesson, DVM, PhD, MPVM, DACVP
Founding VIRC Director/Former Director
Dr. Borjesson is a board-certified veterinary clinical pathologist who has worked in the field of inflammation, cell-pathogen interactions and hematopoietic progenitor cells since 2000. Since 2007, she has been actively engaged in research on veterinary mesenchymal stem cells (MSC). Her lab has developed methods to collect, isolate, expand, freeze, thaw and administer equine (bone marrow, fat, umbilical cord blood and umbilical cord tissue derived), canine (fat and bone marrow derived), ovine, porcine and feline fat-derived MSCs. She co-directs the clinical Regenerative Medicine Laboratory at the Veterinary Medical Teaching Hospital and Directs the Veterinary Institute of Regenerative Cures. Members of her team have developed canine, feline and equine models to assess MSC safety and efficacy. We have also helped faculty in the School of Medicine work with induced large animal models of disease (sheep and pigs). The lab’s current research expertise is in MSC biology and immunomodulation. They focus on naturally occurring models of disease including canine and feline inflammatory diseases and canine spinal cord injury as models for human inflammatory and traumatic diseases. They have begun to define the mechanisms by which MSC alter the immune response and interact with cells of the immune system and have initiated research into how MSCs interact with microbes important to GI health.